These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 6322700

  • 1. [Multidisciplinary treatment for small cell lung cancer].
    Saijo N, Eguchi K, Shimizu E, Shinkai T, Tominaga K, Takahashi K, Sasaki Y, Seki S.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):474-9. PubMed ID: 6322700
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cyclic alternating chemotherapy for small cell carcinoma of the lung.
    Murray N, Shah A, Wilson K, Goldie J, Voss N, Fryer C, Klimo P, Coy P, Hadzic E, Gudauskas G.
    Cancer Treat Rep; 1985 Nov; 69(11):1241-2. PubMed ID: 3004724
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
    Ueoka H, Kiura K, Tabata M, Kamei H, Gemba K, Sakae K, Hiraki Y, Hiraki S, Segawa Y, Harada M.
    Cancer; 1998 Jul 15; 83(2):283-90. PubMed ID: 9669811
    [Abstract] [Full Text] [Related]

  • 5. [Combination chemotherapy and radiotherapy in small cell carcinoma of the lung].
    Yoshida S, Ogata T, Homma T, Kikuchi K, Masuda H, Matsuoka T, Sugiyama K, Noguchi Y, Yoneda S, Fukuda T.
    Gan To Kagaku Ryoho; 1986 Jul 15; 13(7):2331-6. PubMed ID: 3015041
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May 15; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 11. [Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer].
    Homma T, Yoneda S, Fukuda Y, Nakata M, Noguchi Y, Yoshida S.
    Gan To Kagaku Ryoho; 1986 Jul 15; 13(7):2399-403. PubMed ID: 3015045
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of lung cancer--state of the art in 2000].
    Nakanishi Y, Inoue K, Hara N.
    Gan To Kagaku Ryoho; 2000 Jul 15; 27(8):1247-52. PubMed ID: 10945023
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
    Lindgren D, Cadman E, Erichson R, Grann V, Sachs K.
    Cancer Treat Rep; 1984 Sep 15; 68(9):1159-61. PubMed ID: 6090015
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Combination chemotherapy with cis-platinum, adriamycin and mitomycin C (PAM) in the treatment of non-small cell carcinoma of the lung].
    Nakano H, Kurihara M, Saito R, Takise A, Tsuchiya S, Minato K, Takehara K, Saruya T, Kuwabara H, Fueki R.
    Gan To Kagaku Ryoho; 1986 Jun 15; 13(6):2123-7. PubMed ID: 3013099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.